Company coming to state featured on Discovery show
A Philadelphia-area company that is slated to move to Delaware was featured earlier in the week on Health Care Heroes, a show of the...
Delmarva Broadcasting to get new online platform
Marketron, a provider of business software solutions for the media industry, announced that the Delmarva Broadcasting Co., operator of 11 radio stations serving Delaware,...
Viewpoint: State’s life science strategy needs updating
By Brian DiSabatino, President EDiS, Wilmington
The Astra Zeneca restructuring in Delaware was a big blow, but it wasn’t news. When Delaware set out on...
45 employers sign up for congressional delegation’s job fair in Sussex
U.S. Sens. Tom Carper and Chris Coons, and U.S. Representative John Carney announced on Wednesday that nearly 45 employers from around the region have...
Kudos: DuPont, Cover+Rossiter honored
The publication Corporate Responsibility has named DuPont in its Top 100 Best Corporate Citizens ranking.
The list, now in its 14th year, ranks companies based...
SDIX posts bigger continuing operations loss in 2012
Newark Bio-tech company SDIX this week released a filing with regulators showing a bigger operating loss in 2012. The 10K is an annual report...
Solar system installed at Ultrachem in New Castle
EnterSolar, provider of commercial solar systems, announced the completion of a 185 kilowatt solar photovoltaic (PV) system using Motech Americas panels for Ultrachem, Inc.,...
IKEA takes Md.’s largest solar array online at Perryville warehouse
IKEA last week plugged in the solar energy system at its distribution center at Perryville, about 20 miles west of Newark. The system is...
Fisker could file for Chapter 11 this week: Reuters
Reuters is reporting that Fisker Automotive could file for Chapter 11 Bankruptcy protection this week. The news service says the U.S. Department of Energy is...
Newark’s SDIX selling most operations to OriGene
SDIX a provider of biotechnology-based products and services, announced that it has entered into an agreement to sell the assets of its Life...
AstraZeneca’s Medimmune buys early stage company
AstraZeneca announced that MedImmune, its global biologics research and development arm, has acquired Michigan-based AlphaCore Pharma, an early stage biotechnology company in the early...
SevOne keeps close ties with UD
By Kathryn Meier & Rachel Taylor
University of Delaware
From humble beginnings in a small workspace off Main Street in Newark to a recent announcement that...
Court rules against AstraZeneca in asthma drug patent battle
United States District Court in New Jersey ruled that AstraZeneca’s patent protecting Pulmicort Respules in the U.S. is invalid.
The decision deals another blow to...
Life science job fair attracts hundreds
The Delaware Bioscience Association reported more than 300 people participated in the Delaware Bio Life Science Career Fair last week in Newark.
Alok Patel, operations...
InfoSolutions marks 5th anniversary
Info Solutions, an information technology consulting and infrastructure firm and one of the earliest residents of the New Castle County Chamber of Commerce’s Emerging...
AstraZeneca, Watson settle Crestor patent case
AstraZeneca announced that it has entered into a settlement agreement in its US patent infringement litigation against Watson Laboratories, Inc., Actavis, Inc. (formerly known...
Web solutions business gets boost from local incubator
(From the Emerging Enterprise Center)
The Emerging Enterprise Center, the small business incubator of the New Castle County Chamber of Commerce, helps early stage businesses...
$16 million carrier hotel data hub coming to Wilmington
IPR International, LLC announced the signing of agreements with the State of Delaware, IPR International, McConnell Johnson Real Estate, and fiber providers, Sunesys, LLC...
Comcast introduces Upware office suit for small and mid-sized firms
Comcast Corp. announced the Upware marketplace, a suite of cloud-based business solutions that can be purchased through one web portal. The Upware marketplace...
AstraZeneca, Nektar drug shows promise
AstraZeneca again reported promising results from a lengthy safety trial of naloxegol on patients patients with non-cancer related pain and suffering from constipation from...
